title: On further development of barrier modulation as a technique for systemic ocular drug delivery.
authors.affiliation: Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland. hanrahfe@tcd.ie
authors.forename: Finnian
authors.initials: F
authors.lastname: Hanrahan
authors.forename: Matthew
authors.initials: M
authors.lastname: Campbell
authors.forename: Anh T
authors.initials: AT
authors.lastname: Nguyen
authors.forename: Mayu
authors.initials: M
authors.lastname: Suzuki
authors.forename: Anna-Sophia
authors.initials: AS
authors.lastname: Kiang
authors.forename: Lawrence C
authors.initials: LC
authors.lastname: Tam
authors.forename: Oliviero L
authors.initials: OL
authors.lastname: Gobbo
authors.forename: Sorcha Ní
authors.initials: SN
authors.lastname: Dhubhghaill
authors.forename: Marian M
authors.initials: MM
authors.lastname: Humphries
authors.forename: Paul F
authors.initials: PF
authors.lastname: Kenna
authors.forename: Pete
authors.initials: P
authors.lastname: Humphries
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001813:Blood-Retinal Barrier / Q000187:drug effects* / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D000069579:Ranibizumab; D055213:Retinal Pigment Epithelium / Q000187:drug effects / Q000378:metabolism; D019108:Tight Junctions / Q000378:metabolism; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab